Anika Therapeutics, Inc.

Anika Therapeutics develops, manufactures and commercializes hyaluronic acid (HA)-based orthopedic products. It works with clinicians to advance regenerative solutions and treatments for osteoarthritis pain, including HA injections and technologies designed to repair damaged tissue. Its portfolio focuses on early-intervention orthopedic care and joint preservation, with the mission of helping patients restore active living through science-driven products for patients and clinicians worldwide.